CD40-CD40 LIGAND (CD40L) INTERACTIONS AND X-LINKED HYPERIGM SYNDROME (HIGMX-1)

被引：20

作者：

RAMESH, N ^{[1
]}

MORIO, T ^{[1
]}

FULEIHAN, R ^{[1
]}

WORM, M ^{[1
]}

HORNER, A ^{[1
]}

TSITSIKOV, E ^{[1
]}

CASTIGLI, E ^{[1
]}

GEHA, RS ^{[1
]}

机构：

[1] HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115

来源：

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1995年 / 76卷 / 03期

关键词：

D O I：

10.1016/S0090-1229(95)90252-X

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Interactions between the B cell surface antigen CD40 and its ligand (CD40L) expressed on activated T cells play a critical role in isotype switching This is illustrated by failure of isotype switching in patients with X-linked hyperIgM syndrome in whom the CD40L gene is mutated and by failure of isotype switching of CD40-deficient mice in response to T-cell-dependent antigens. We review these findings and discuss the signaling mechanisms of CD40 and the developmental control and transcriptional regulation of CD40L expression. (C) 1995 Academic Press, Inc.

引用

页码：S208 / S213

页数：6

共 50 条

[41] The CD40/CD40 ligand (CD40L) pathway plays a role in primary hemostasis and platelet function
Langer, F
Ingersoll, SB
Amirkhosravi, A
Meyer, TV
Siddiqui, FA
Rocca, S
Ahmad, S
Walker, JM
Amaya, M
Desai, H
Francis, JL
BLOOD, 2004, 104 (11) : 436A - 436A
[42] Evidence for a role of the CD40/CD40 ligand (CD40L) pathway in primary hemostasis and platelet function
Langer, F
Amirkhosravi, A
Meyer, TV
Ingersoll, SB
Rocca, S
Siddiqi, FA
Ahmad, S
Walker, JM
Amaya, M
Francis, JL
CIRCULATION, 2004, 110 (17) : 328 - 329
[43] Blocking CD40-CD40L interactions in Sjogren syndrome
McHugh, Jessica
NATURE REVIEWS RHEUMATOLOGY, 2019, 15 (05) : 252 - 252
[44] Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia
Garlichs, CD
Kozina, S
Fateh-Moghadam, S
Tomandl, B
Stumpf, C
Eskafi, S
Raaz, D
Schmeisser, A
Yilmaz, A
Ludwig, J
Neundörfer, B
Daniel, WG
STROKE, 2003, 34 (06) : 1412 - 1417
[45] CD40/CD40L system and vascular disease
F. Santilli
S. Basili
P. Ferroni
G. Davì
Internal and Emergency Medicine, 2007, 2 : 256 - 268
[46] Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: A role of CD40 in regulatory T cell development
Kumanogoh, A
Wang, XS
Lee, I
Watanabe, C
Kamanaka, M
Shi, W
Yoshida, K
Sato, T
Habu, S
Itoh, M
Sakaguchi, N
Sakaguchi, S
Kikutani, H
JOURNAL OF IMMUNOLOGY, 2001, 166 (01): : 353 - 360
[47] CD40/CD40L system and vascular disease
Santilli, F.
Basili, S.
Ferroni, P.
Davi, G.
INTERNAL AND EMERGENCY MEDICINE, 2007, 2 (04) : 256 - 268
[48] Homocysteine modulates the CD40/CD40L system
Prontera, Cesaria
Martelli, Nicola
Evangelista, Virgilio
D'Urbano, Etrusca
Manarini, Stefano
Recchiuti, Antonio
Dragani, Alfredo
Passeri, Cecilia
Davi, Giovanni
Romano, Mario
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (22) : 2182 - 2190
[49] A critical role for CD40-CD40 ligand interactions in amplification of the mucosal CD8 T cell response
Lefrançois, L
Olson, S
Masopust, D
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (09): : 1275 - 1283
[50] CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets
Barbe-Tuana, Florencia M.
Klein, Dagmar
Ichii, Hirohito
Berman, Dora M.
Coffey, Lane
Kenyon, Norma S.
Ricordi, Camillo
Pastori, Ricardo L.
DIABETES, 2006, 55 (09) : 2437 - 2445

← 1 2 3 4 5 →